Physician profile
John A Distasio
NPI 1457351611
$839.74
in general payments reported to CMS, 2019-2025
16 companies · $327 in 2025
The $327 reported for 2025 was more than what 86% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.57 · 2020: $32.76 · 2021: $27.48 · 2022: $32.37 · 2023: $40.52 · 2024: $283 · 2025: $327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $651.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $650.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $200.81 | 2019-2025 | |
| Glaxosmithkline, LLC. | $113.22 | 2024-2025 | Bexsero, Penmenvy |
| Ironshore Pharmaceuticals INC. | $98.11 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $85.44 | 2024-2025 | |
| Corium, LLC | $56.91 | 2024-2025 | Azstarys |
| Sanofi Pasteur INC. | $55.67 | 2022-2024 | |
| Collegium Pharmaceutical, INC. | $38.85 | 2025 | Jornay Pm |
| Merck Sharp & Dohme LLC | $38.84 | 2023-2024 | Vaxneuvance, Gardasil 9, Gardasil |
| Tris Pharma INC | $28.17 | 2019-2021 | |
| Kaleo, INC. | $27.67 | 2020-2021 | |
| Acadia Pharmaceuticals INC | $22.75 | 2025 | Daybue |
| Kowa Pharmaceuticals America, INC. | $17.85 | 2024 | Zoryve |
| Sobi, INC | $15.91 | 2022 | |
| Neos Therapeutics, Lp | $13.53 | 2019 | |
| Genentech USA, INC. | $13.15 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $12.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Distasio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.